Joanne Wuensch
Stock Analyst at Citigroup
(4.36)
# 378
Out of 5,124 analysts
441
Total ratings
64.6%
Success rate
11.77%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $98 → $94 | $89.92 | +4.54% | 23 | Dec 11, 2025 | |
| SYK Stryker | Maintains: Buy | $455 → $420 | $351.47 | +19.50% | 15 | Dec 11, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $5.5 → $9.1 | $7.93 | +14.75% | 14 | Dec 11, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $215 → $232 | $206.95 | +12.10% | 16 | Dec 11, 2025 | |
| ITGR Integer Holdings | Maintains: Neutral | $69 → $75 | $78.43 | -4.37% | 9 | Dec 11, 2025 | |
| GKOS Glaukos | Maintains: Buy | $113 → $125 | $112.91 | +10.71% | 23 | Dec 11, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $83 → $88 | $82.02 | +7.29% | 8 | Dec 11, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $62 → $75 | $72.80 | +3.02% | 8 | Dec 11, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $96 → $101 | $85.25 | +18.48% | 22 | Dec 11, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $16 → $22 | $21.98 | +0.09% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $77 | $66.37 | +16.02% | 17 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $285 → $350 | $310.91 | +12.57% | 26 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $650 → $635 | $566.36 | +12.12% | 18 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $88 | $80.15 | +9.79% | 10 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $88 | $81.96 | +7.37% | 22 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $12 → $11 | $12.42 | -11.43% | 16 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $21 | $19.11 | +9.89% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $242 | $177.44 | +36.38% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $96.06 | +16.59% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $125.29 | +23.71% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $17.08 | -12.18% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.21 | +87.78% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $284.24 | +33.69% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $95.35 | +31.10% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $194.07 | +28.82% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $78.81 | -12.45% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $240.87 | -47.27% | 6 | Dec 10, 2018 |
Zimmer Biomet Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $98 → $94
Current: $89.92
Upside: +4.54%
Stryker
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $351.47
Upside: +19.50%
Sight Sciences
Dec 11, 2025
Maintains: Neutral
Price Target: $5.5 → $9.1
Current: $7.93
Upside: +14.75%
Johnson & Johnson
Dec 11, 2025
Maintains: Buy
Price Target: $215 → $232
Current: $206.95
Upside: +12.10%
Integer Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $69 → $75
Current: $78.43
Upside: -4.37%
Glaukos
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $112.91
Upside: +10.71%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Neutral
Price Target: $83 → $88
Current: $82.02
Upside: +7.29%
Establishment Labs Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $62 → $75
Current: $72.80
Upside: +3.02%
Edwards Lifesciences
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $85.25
Upside: +18.48%
Tandem Diabetes Care
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $21.98
Upside: +0.09%
Dec 11, 2025
Maintains: Buy
Price Target: $75 → $77
Current: $66.37
Upside: +16.02%
Dec 11, 2025
Upgrades: Buy
Price Target: $285 → $350
Current: $310.91
Upside: +12.57%
Dec 11, 2025
Downgrades: Neutral
Price Target: $650 → $635
Current: $566.36
Upside: +12.12%
Dec 11, 2025
Downgrades: Neutral
Price Target: $77 → $88
Current: $80.15
Upside: +9.79%
Dec 8, 2025
Maintains: Neutral
Price Target: $72 → $88
Current: $81.96
Upside: +7.37%
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $12.42
Upside: -11.43%
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $19.11
Upside: +9.89%
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $177.44
Upside: +36.38%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $96.06
Upside: +16.59%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $125.29
Upside: +23.71%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $17.08
Upside: -12.18%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.21
Upside: +87.78%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $284.24
Upside: +33.69%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $95.35
Upside: +31.10%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $194.07
Upside: +28.82%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $78.81
Upside: -12.45%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $240.87
Upside: -47.27%